444 related articles for article (PubMed ID: 11416134)
1. Redistribution of glycolipid raft domain components induces insulin-mimetic signaling in rat adipocytes.
Müller G; Jung C; Wied S; Welte S; Jordan H; Frick W
Mol Cell Biol; 2001 Jul; 21(14):4553-67. PubMed ID: 11416134
[TBL] [Abstract][Full Text] [Related]
2. Insulin-mimetic signaling by the sulfonylurea glimepiride and phosphoinositolglycans involves distinct mechanisms for redistribution of lipid raft components.
Müller G; Jung C; Wied S; Welte S; Frick W
Biochemistry; 2001 Dec; 40(48):14603-20. PubMed ID: 11724574
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol depletion blocks redistribution of lipid raft components and insulin-mimetic signaling by glimepiride and phosphoinositolglycans in rat adipocytes.
Müller G; Hanekop N; Wied S; Frick W
Mol Med; 2002 Mar; 8(3):120-36. PubMed ID: 12142544
[TBL] [Abstract][Full Text] [Related]
4. Cross talk of pp125(FAK) and pp59(Lyn) non-receptor tyrosine kinases to insulin-mimetic signaling in adipocytes.
Müller G; Wied S; Frick W
Mol Cell Biol; 2000 Jul; 20(13):4708-23. PubMed ID: 10848597
[TBL] [Abstract][Full Text] [Related]
5. Interaction of phosphatidylinositolglycan(-peptides) with plasma membrane lipid rafts triggers insulin-mimetic signaling in rat adipocytes.
Müller G; Jung C; Frick W; Bandlow W; Kramer W
Arch Biochem Biophys; 2002 Dec; 408(1):7-16. PubMed ID: 12485598
[TBL] [Abstract][Full Text] [Related]
6. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans.
Müller G; Wied S; Piossek C; Bauer A; Bauer J; Frick W
Mol Med; 1998 May; 4(5):299-323. PubMed ID: 9642681
[TBL] [Abstract][Full Text] [Related]
7. Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin.
Müller G; Frick W
Cell Mol Life Sci; 1999 Dec; 56(11-12):945-70. PubMed ID: 11212327
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lipid raft proteins by glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C in rat adipocytes.
Müller G; Schulz A; Wied S; Frick W
Biochem Pharmacol; 2005 Mar; 69(5):761-80. PubMed ID: 15710354
[TBL] [Abstract][Full Text] [Related]
9. Interaction of phosphoinositolglycan(-peptides) with plasma membrane lipid rafts of rat adipocytes.
Müller G; Hanekop N; Kramer W; Bandlow W; Frick W
Arch Biochem Biophys; 2002 Dec; 408(1):17-32. PubMed ID: 12485599
[TBL] [Abstract][Full Text] [Related]
10. Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.
Frick W; Bauer A; Bauer J; Wied S; Müller G
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):163-81. PubMed ID: 9806898
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
[TBL] [Abstract][Full Text] [Related]
12. Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1.
Lee H; Park DS; Wang XB; Scherer PE; Schwartz PE; Lisanti MP
J Biol Chem; 2002 Sep; 277(37):34556-67. PubMed ID: 12091389
[TBL] [Abstract][Full Text] [Related]
13. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette.
Lee H; Volonte D; Galbiati F; Iyengar P; Lublin DM; Bregman DB; Wilson MT; Campos-Gonzalez R; Bouzahzah B; Pestell RG; Scherer PE; Lisanti MP
Mol Endocrinol; 2000 Nov; 14(11):1750-75. PubMed ID: 11075810
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
Frick W; Bauer A; Bauer J; Wied S; Müller G
Biochemistry; 1998 Sep; 37(38):13421-36. PubMed ID: 9748349
[TBL] [Abstract][Full Text] [Related]
15. Caveolin scaffolding region and the membrane binding region of SRC form lateral membrane domains.
Wanaski SP; Ng BK; Glaser M
Biochemistry; 2003 Jan; 42(1):42-56. PubMed ID: 12515538
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14).
Lee H; Woodman SE; Engelman JA; Volonté D; Galbiati F; Kaufman HL; Lublin DM; Lisanti MP
J Biol Chem; 2001 Sep; 276(37):35150-8. PubMed ID: 11451957
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.
Couet J; Sargiacomo M; Lisanti MP
J Biol Chem; 1997 Nov; 272(48):30429-38. PubMed ID: 9374534
[TBL] [Abstract][Full Text] [Related]
18. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells.
Sargiacomo M; Sudol M; Tang Z; Lisanti MP
J Cell Biol; 1993 Aug; 122(4):789-807. PubMed ID: 8349730
[TBL] [Abstract][Full Text] [Related]
19. Insulin stimulates the tyrosine phosphorylation of caveolin.
Mastick CC; Brady MJ; Saltiel AR
J Cell Biol; 1995 Jun; 129(6):1523-31. PubMed ID: 7540611
[TBL] [Abstract][Full Text] [Related]
20. Short-term leptin-dependent inhibition of hepatic gluconeogenesis is mediated by insulin receptor substrate-2.
Anderwald C; Müller G; Koca G; Fürnsinn C; Waldhäusl W; Roden M
Mol Endocrinol; 2002 Jul; 16(7):1612-28. PubMed ID: 12089355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
